Calibrate Stock
Calibrate is a digital metabolic health business that is changing the way the world treats weight.
Sign up today and learn more about Calibrate Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Calibrate Stock
Calibrate is a digital metabolic health business that provides a virtual program for weight loss. It is creating a new category by improving metabolic health to drive long-term, sustainable weight loss with a program designed by world leaders in obesity and nutrition science. Calibrate combines FDA-approved metabolic medication with a holistic curriculum and 1:1 virtual coaching sessions that drive lasting behavior change. The company was founded in 2020 and is headquartered in New York.
Funding History
| January 2021 | $2.1M |
|---|---|
| January 2021 | $3.0M |
| January 2021 | $15.1M |
| July 2021 | $76.1M |
Management
Founder, CEO
Isabelle Kenyon
Chief Medical Officer
Kim Boyd
Chief Marketing Officer
Katy Marshall
COO
Claudia Huapaya
Board Member
Brian Singerman
Medical Director
Sona Shah
Director, Business Operations
Sintha Rajasingham
Board Member
Emily Melton
Board Member
Kira Wampler
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
